stockrowTravere Therapeutics, Inc.
TVTX Healthcare Biotechnology
Travere Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $490.7 million, up 110.5% from fiscal 2024.
- Revenue
- +36.2%
- EPS
- −290.7%
- Free cash flow
- +6,379.8%
- Total debt
- +93.8%
Quarter to September 2026, against a year earlier
Follow TVTX
Alert me
Travere Therapeutics, Inc. (TVTX) Operating margin
Travere Therapeutics, Inc.'s operating margin over the twelve months to 30 September 2026 was −20.5%, down 7.7 percentage points from fiscal 2025 (−12.8%). Over the past ten years it has ranged from −292.2% (fiscal 2022) to −12.8% (fiscal 2025) — the current reading is the highest in ten years. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −12.8% | 126.08 |
| FY2024 | −138.9% | 128.36 |
| FY2023 | −267.2% | 24.93 |
| FY2022 | −292.2% | (140.90) |
| FY2021 | −151.3% | (62.44) |
| FY2020 | −88.8% | (10.49) |
| FY2019 | −78.3% | (29.61) |
| FY2018 | −48.7% | (14.01) |
| FY2017 | −34.7% | 8.86 |
| FY2016 | −43.6% | 7.22 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −30.3% | (32.66) |
| Jun 2026 | 2.33% | 31.35 |
| Mar 2026 | −29.0% | (4.01) |
| Dec 2025 | −25.0% | (40.13) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| COGT Cogent Biosciences, Inc. compare | 0.00% |
| MANE Veradermics Incorporated compare | 0.00% |
| ERAS Erasca, Inc. compare | 0.00% |
| DFTX Definium Therapeutics, Inc. compare | 0.00% |
| EWTX Edgewise Therapeutics, Inc. compare | 0.00% |
| LEGN Legend Biotech Corporation Sponsored ADR compare | −5.06% |
| TVTX Travere Therapeutics, Inc. | −20.5% |
| CRSP CRISPR Therapeutics AG compare | −2,114.8% |
| DNTH Dianthus Therapeutics, Inc. compare | −8,683.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on TVTX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement